I was wondering if SGP will test boceprevir with Pegasys as I'd expect modestly better results (such as higher proportion of patients able to achieve SVR with a shortened course of therapy) for boceprevir if dosed with Pegasys. I'm not aware of such study.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.